A developer and an investment firm have joined together to add yet another biotech building to Boston’s skyline. And today, a private equity firm has joined the venture.
KKR announced today that it completed an investment and is now in a joint venture with WS Development and the Public Sector Pension Investment Board for 400 Summer Street, a life science tower under construction in Boston’s Seaport District. The amount that KKR invested into the construction of the project remains undisclosed.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,